aspirin has been researched along with ristocetin in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (44.83) | 18.7374 |
| 1990's | 9 (31.03) | 18.2507 |
| 2000's | 2 (6.90) | 29.6817 |
| 2010's | 5 (17.24) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chediak, J; Cohen, I; Maxey, B; Telfer, MC; Vander Laan, B | 1 |
| Hoyer, LW | 1 |
| Ts'ao, CH | 1 |
| Weiss, HJ | 1 |
| D'Souza, S; Dowling, SV; Ekert, H; Muntz, RH | 1 |
| Baumgartner, HR; Tschopp, TB; Weiss, HJ | 1 |
| Flute, PT; Tann, G | 1 |
| Takahashi, O | 1 |
| Hakenkamp, K; Ryan, WL; Sullivan, E | 1 |
| Isom, OW; Ko, W; Krieger, KH; Lazenby, WD; Lynch, CC; Russo, I; Zadeh, BJ; Zelano, JA | 1 |
| Dietrich, G; Kretschmer, V; Schikor, B; Söhngen, D | 1 |
| Lattuada, A; Lombardi, R; Mannucci, PM; Perticucci, E; Remuzzi, G; Valsecchi, R | 1 |
| McKeown, LP; Rick, ME; Sacher, RA; Williams, SB | 1 |
| Duckert, F; Marbet, GA; Sahaphong, S; Sathiropas, P | 1 |
| Dreyfus, MD; Jenkins, CS; Larrieu, MJ; Meyer, D | 1 |
| Hart, SJ; Krajewski, DV; Sorensen, PG; Ts'ao, C | 1 |
| Jackson, SP; Mitchell, CA; Rabinowitz, I; Salem, HH; Schoenwaelder, SM; Yuan, Y | 1 |
| Belcher, PR; Drossos, GE; Evans, RD; Menys, VC; Noble, MI; Pillai, R; Westaby, S | 1 |
| Clezardin, P; Delmas, PD; Drouin, J; Hanss, M; Kaplan, C; Kehrel, B; Morel-Kopp, MC; Serre, CM | 1 |
| Calza, R; Cattani, L; Ferri, A; Pellegrini, A | 1 |
| Cole, AT; Hawkey, CJ; Heptinstall, S; May, JA | 1 |
| Bahr, RD; Dalesandro, MR; Grabletz, LB; Gumbs, CI; Gurbel, PA; Ohman, EM; Serebruany, VL; Shustov, AR; Topol, EJ | 1 |
| Durdil, V; Hadacová, I; Hájek, P; Malý, M; Mates, M; Vojácek, J | 1 |
| Brannath, W; Graff, J; Heinrich, W; Klinkhardt, U; Krischek, B; Nemeh, A; Schenk, J; Wenzel, E; Wenzel, T; Wieding, U | 1 |
| Adachi, S; Akamatsu, S; Doi, T; Enomoto, Y; Iwama, T; Kozawa, O; Matsushima-Nishiwaki, R; Niwa, M; Ogura, S; Tokuda, H; Yoshimura, S | 1 |
| Dai, K; Li, S; Liu, G; Shi, Q; Wang, Y; Wang, Z; Zhang, W | 1 |
| Lindhoff-Last, E; Mani, H; Wolf, Z | 1 |
| Handa, M; Ikeda, Y; Okamura, Y; Watanabe, N; Yoshida, H | 1 |
| Barandon, L; Calderon, J; Fiore, M; James, C; Mouton, C; Ouattara, A; Picard, F | 1 |
2 review(s) available for aspirin and ristocetin
| Article | Year |
|---|---|
Von Willebrand's disease.
Topics: Animals; Antibodies; Aspirin; Blood Platelets; Blood Transfusion; Disease Models, Animal; Dogs; Factor VIII; Hemostasis; History, 20th Century; Humans; Platelet Aggregation; Ristocetin; Swine; von Willebrand Diseases; von Willebrand Factor | 1976 |
[Significance of platelet function tests].
Topics: Adenosine Diphosphate; Arachidonic Acid; Aspirin; Blood Platelet Disorders; Clopidogrel; Collagen; Hemorrhagic Disorders; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Prognosis; Ristocetin; Ticlopidine | 2010 |
2 trial(s) available for aspirin and ristocetin
| Article | Year |
|---|---|
Treatment with desmopressin acetate in routine coronary artery bypass surgery to improve postoperative hemostasis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Loss, Surgical; Blood Transfusion; Coronary Artery Bypass; Deamino Arginine Vasopressin; Female; Hemostasis, Surgical; Humans; Male; Middle Aged; Platelet Aggregation; Prospective Studies; Ristocetin; Time Factors | 1990 |
Platelet responses to several agonists and combinations of agonists in whole blood: a placebo controlled comparison of the effects of a once daily dose of plain aspirin 300 mg, plain aspirin 75 mg and enteric coated aspirin 300 mg, in man.
Topics: Adenosine Diphosphate; Adult; Arachidonic Acid; Aspirin; Blood Platelets; Coagulants; Collagen; Dose-Response Relationship, Drug; Epinephrine; Female; Humans; Male; Placebos; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Ristocetin; Streptokinase; Tablets, Enteric-Coated | 1997 |
25 other study(ies) available for aspirin and ristocetin
| Article | Year |
|---|---|
Cycles of agglutination-disagglutination induced by ristocetin in thrombasthenic platelets.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Adolescent; Adult; Aspirin; Child; Child, Preschool; Creatine Kinase; Dose-Response Relationship, Drug; Female; Humans; Infant; Male; Periodicity; Phosphocreatine; Platelet Aggregation; Purpura, Thrombocytopenic; Ristocetin; Time Factors | 1979 |
Comparable inhibition of aggregation of PRP of neonates and adults by aspirin.
Topics: Adenosine Diphosphate; Adult; Aging; Aspirin; Collagen; Dose-Response Relationship, Drug; Epinephrine; Humans; Infant, Newborn; Platelet Aggregation; Ristocetin | 1977 |
Abnormalities of factor VIII and platelet aggregation--use of ristocetin in diagnosing the von Willebrand syndrome.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Aspirin; Blood Coagulation Tests; Blood Platelets; Collagen; Epinephrine; Factor VIII; Glass; Humans; Platelet Adhesiveness; Platelet Aggregation; Ristocetin; von Willebrand Diseases | 1975 |
Ristocetin in the diagnosis of von willebrand's disease: a comparison of rate and percent of aggregation with levels of the plasma factor(s) necessary for ristocetin aggregation.
Topics: Antigens; Aspirin; Blood Coagulation Factors; Dose-Response Relationship, Drug; Factor VIII; Humans; Platelet Aggregation; Ristocetin; von Willebrand Diseases; von Willebrand Factor | 1975 |
[Adhesion and aggregation in the subendothelium: hereditary platelet function disorder].
Topics: Aorta; Aspirin; Endothelium; Humans; Platelet Adhesiveness; Platelet Aggregation; Ristocetin; von Willebrand Diseases | 1975 |
Proceedings: Drug inhibition of ristocetin-induced platelet aggregation.
Topics: Aspirin; Humans; In Vitro Techniques; Phenylbutazone; Platelet Aggregation; Ristocetin | 1975 |
Some properties of rat platelet aggregation and effects of butylated hydroxytoluene, warfarin and aspirin.
Topics: Adenosine Diphosphate; Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Blood Coagulation Factors; Butylated Hydroxytoluene; Collagen; Epinephrine; Male; Platelet Activating Factor; Platelet Aggregation; Rats; Rats, Inbred Strains; Ristocetin; Warfarin | 1991 |
A new platelet function test.
Topics: Adenosine Diphosphate; Arachidonic Acid; Arachidonic Acids; Aspirin; Bleeding Time; Blood Specimen Collection; Calcium; Collagen; Edetic Acid; Humans; Platelet Aggregation; Platelet Count; Platelet Function Tests; Ristocetin | 1990 |
In vitro bleeding test--a simple method for the detection of aspirin effects on platelet function.
Topics: Aspirin; Blood Platelets; Calcium Chloride; Humans; In Vitro Techniques; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Ristocetin | 1989 |
Supranormal von Willebrand factor multimers in scleroderma.
Topics: Adult; Aspirin; Female; Humans; Macromolecular Substances; Male; Middle Aged; Molecular Weight; Ristocetin; Scleroderma, Systemic; von Willebrand Factor | 1989 |
Thrombocytopenia associated with pregnancy in a patient with type IIB von Willebrand's disease.
Topics: Adult; Aspirin; Blood Coagulation Tests; Bucladesine; Epoprostenol; Female; Humans; Platelet Aggregation; Pregnancy; Pregnancy Complications, Hematologic; Ristocetin; Thrombocytopenia; von Willebrand Diseases | 1987 |
Detection of small inhibitory effects of acetylsalicylic acid (ASA) by platelet impedance aggregometry in whole blood.
Topics: Adult; Aged; Aspirin; Collagen; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Ristocetin | 1988 |
Willebrand factor and ristocetin. I. Mechanism of rustocetin-induced platelet aggregation.
Topics: Adenosine Diphosphate; Albumins; Aspirin; Carbon Radioisotopes; Chromatography, Gel; Dose-Response Relationship, Drug; Factor VIII; Fibrinogen; gamma-Globulins; Hemophilia A; Humans; Platelet Adhesiveness; Platelet Aggregation; Ristocetin; Serotonin; von Willebrand Diseases | 1974 |
Opposite effect of lysine on platelet aggregation induced by arachidonate and by other aggregants.
Topics: Adenosine Diphosphate; Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Collagen; Dose-Response Relationship, Drug; Drug Synergism; Humans; Lysine; Male; Malondialdehyde; Platelet Aggregation; Rats; Rats, Inbred Strains; Ristocetin; Serotonin | 1982 |
Adhesion receptor activation of phosphatidylinositol 3-kinase. von Willebrand factor stimulates the cytoskeletal association and activation of phosphatidylinositol 3-kinase and pp60c-src in human platelets.
Topics: Aspirin; Biological Transport; Blood Platelets; Cell Adhesion; Cell Compartmentation; Cytoskeleton; Edetic Acid; Enzyme Activation; Glycosylphosphatidylinositols; Humans; Phosphatidylinositol 3-Kinases; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Platelet Aggregation; Platelet Membrane Glycoproteins; Proto-Oncogene Proteins pp60(c-src); Receptors, Cytoadhesin; Ristocetin; Signal Transduction; von Willebrand Factor | 1994 |
Macroaggregation of platelets in plasma, as distinct from microaggregation in whole blood (and plasma), as determined using optical aggregometry and platelet counting respectively, is specifically impaired following cardiopulmonary bypass in man.
Topics: Aprotinin; Aspirin; Blood; Blood Loss, Surgical; Cardiopulmonary Bypass; Collagen; Hirudins; Humans; Nephelometry and Turbidimetry; Plasma; Platelet Activation; Platelet Aggregation; Platelet Count; Platelet Function Tests; Recombinant Proteins; Ristocetin | 1994 |
Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells.
Topics: Antibodies, Monoclonal; Aspirin; Bernard-Soulier Syndrome; Blood Platelets; Cell Communication; Humans; In Vitro Techniques; Membrane Glycoproteins; Osteosarcoma; P-Selectin; Platelet Aggregation; Platelet Membrane Glycoproteins; Ristocetin; Thrombasthenia; Thrombospondins; Tumor Cells, Cultured | 1993 |
Two distinct mechanisms of inhibition of platelets aggregation by acetylsalicylic acid.
Topics: Arachidonic Acid; Aspirin; Blood Platelets; Humans; Phospholipases A; Platelet Aggregation; Platelet Aggregation Inhibitors; Ristocetin; Thromboxane A2; von Willebrand Factor | 1994 |
Depressed platelet status in an elderly patient with hemorrhagic stroke after thrombolysis for acute myocardial infarction. GUSTO-III Investigators.
Topics: Adenosine Diphosphate; Aged; Aged, 80 and over; Antigens, CD; Aspirin; Blood Platelets; Cerebral Hemorrhage; Cerebrovascular Disorders; Collagen; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Follow-Up Studies; Humans; Male; Membrane Glycoproteins; Myocardial Infarction; P-Selectin; Paraplegia; Plasminogen Activators; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Endothelial Cell Adhesion Molecule-1; Platelet Membrane Glycoproteins; Prospective Studies; Receptors, Very Late Antigen; Ristocetin; Tetraspanin 29; Thrombin; Thrombolytic Therapy; Tissue Plasminogen Activator; Vitronectin | 1998 |
[Assessment of speed of an anti-platelet effect after two different doses of acetylsalicylic acid by flocculation].
Topics: Adenosine Diphosphate; Adult; Aspirin; Collagen; Dose-Response Relationship, Drug; Female; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Ristocetin | 2004 |
Role of the retention test Homburg in evaluating platelet hyperactivity and in monitoring therapy with antiplatelet drugs.
Topics: Abciximab; Adenosine Diphosphate; Antibodies, Monoclonal; Aspirin; Blood Platelets; Cell Shape; Clopidogrel; Collagen; Drug Monitoring; Humans; Immunoglobulin Fab Fragments; P-Selectin; Pilot Projects; Plasma; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Function Tests; Prostaglandins; Ristocetin; Ticlopidine | 2005 |
Thromboxane A(2) promotes soluble CD40 ligand release from human platelets.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Aged; Aspirin; Atherosclerosis; Blood Platelets; Carotid Artery Diseases; CD40 Ligand; Female; Humans; Male; MAP Kinase Kinase 4; Methacrylates; Middle Aged; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyrazoles; Ristocetin; Thromboxane A2 | 2010 |
Mechanism of platelet functional changes and effects of anti-platelet agents on in vivo hemostasis under different gravity conditions.
Topics: Actin Cytoskeleton; Adenosine Diphosphate; Animals; Aspirin; Blood Platelets; Calcium; Chelating Agents; Contractile Proteins; Egtazic Acid; Filamins; Hemostasis; Humans; Hypergravity; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Microfilament Proteins; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIb-IX Complex; Protein Binding; Ristocetin; Thrombosis; Time Factors; Tirofiban; Tyrosine; Weightlessness Simulation | 2010 |
Shear-dependent suppression of platelet thrombus formation by phosphodiesterase 3 inhibition requires low levels of concomitant Gs-coupled receptor stimulation.
Topics: Aspirin; Cyclic AMP; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Dose-Response Relationship, Drug; GTP-Binding Protein alpha Subunits, Gs; Hemostasis; Humans; Ligands; Platelet Aggregation; Quinolines; Ristocetin; Shear Strength; Tirofiban; Tyrosine; Urea; von Willebrand Factor | 2011 |
Assessment of platelet function with light transmission aggregometry in 24 patients supported with a continuous-flow left ventricular assist device: a single-center experience.
Topics: Aged; Arachidonic Acid; Aspirin; Drug Administration Schedule; Drug Monitoring; Female; France; Heart Failure; Heart-Assist Devices; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Prospective Studies; Prosthesis Design; Risk Factors; Ristocetin; Thromboembolism; Time Factors; Treatment Outcome; Ventricular Function, Left | 2014 |